Skip header and navigation

1 records – page 1 of 1.

A 3-year follow-up of sun behavior in patients with cutaneous malignant melanoma.

https://arctichealth.org/en/permalink/ahliterature106960
Source
JAMA Dermatol. 2014 Feb;150(2):163-8
Publication Type
Article
Date
Feb-2014
Author
Luise Winkel Idorn
Pameli Datta
Jakob Heydenreich
Peter Alshede Philipsen
Hans Christian Wulf
Author Affiliation
Dermatological Research Department D92, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
Source
JAMA Dermatol. 2014 Feb;150(2):163-8
Date
Feb-2014
Language
English
Publication Type
Article
Keywords
Adult
Case-Control Studies
Denmark
Female
Follow-Up Studies
Health Behavior
Humans
Male
Melanoma - etiology - pathology
Middle Aged
Prospective Studies
Risk factors
Skin Neoplasms - etiology - pathology
Sunlight - adverse effects
Time Factors
Ultraviolet Rays - adverse effects
Abstract
IMPORTANCE UV radiation (UVR) exposure is the primary environmental risk factor for developing cutaneous malignant melanoma (CMM). OBJECTIVE To measure changes in sun behavior from the first until the third summer after the diagnosis of CMM using matched controls as a reference. DESIGN, SETTING, AND PARTICIPANTS Three-year follow-up, observational, case-control study performed from May 7 to September 22, 2009, April 17 to September 15, 2010, and May 6 to July 31, 2011, at a university hospital in Denmark of 21 patients with CMM and 21 controls matched to patients by sex, age, occupation, and constitutive skin type participated in the study. Exposure to UVR was assessed the first and second summers (n=20) and the first and third summers (n=22) after diagnosis. Data from 40 participants were analyzed. MAIN OUTCOMES AND MEASURES Exposure to UVR was assessed by personal electronic UVR dosimeters that measured time-related UVR in standard erythema dose (SED) and corresponding sun diaries (mean, 74 days per participant each participation year). RESULTS Patients' daily UVR dose and UVR dose in connection with various behaviors increased during follow-up (quantified as an increase in daily UVR dose each year; all days: mean, 0.3 SED; 95% CI, 0.05-0.5 SED; days with body exposure: mean, 0.6 SED; 95% CI, 0.07-1.2 SED; holidays: mean, 1.2 SED; 95% CI, 0.3-2.1 SED; days abroad: 1.9 SED; 95% CI, 0.4-3.4 SED; and holidays with body exposure: mean, 2.3 SED; 95% CI, 1.1-3.4 SED). After the second year of follow-up, patients' UVR dose was higher than that of controls, who maintained a stable UVR dose. No difference was found between groups in the number of days with body exposure or the number of days using sunscreen in the second and third years of follow-up. CONCLUSIONS AND RELEVANCE Our findings suggest that patients with CMM do not maintain a cautious sun behavior in connection with an increase in UVR exposure, especially on days with body exposure, when abroad, and on holidays.
PubMed ID
24080851 View in PubMed
Less detail